FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-institutional, Patient-Level, Meta-analysis and Systematic Review.
Journal Information
Full Title: Ann Surg Oncol
Abbreviation: Ann Surg Oncol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: General Surgery
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Disclosures Sarah Hoffe: Galera Pharmaceuticals, Institutional Principal Investigator for the GRECO-2 randomized international study for which my cancer center receives funding to support the trial, it is a pancreas trial that includes SBRT. D.E., B.A., R.P share first authorship."
"Funding Open access funding provided by University of Zurich. None."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025